Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in Australia

Cameron JK, Chandrasiri U, Millar J, Aitken JF, Cramb S, Dunn J, Frydenberg M, Rashid P, Mengersen K, Chambers SK, Baade PD, Smith DP

(2023), PLoS One, 18(11), e0293954

DOI: 10.1371/journal.pone.0293954

AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model-based dose calculation algorithms in brachytherapy

Beaulieu L, Ballester F, Granero D, Tedgren A, Haworth A, Lowenstein JR, Ma Y, Mourtada F. Papagiannis P. Rivard MJ, Siebert FA, Sloboda RS, Smith RL, Thomson RM, Verhaegen F, Fonseca G, Vijande J

(2023), Medical Physics, 50(8), e946-e960

DOI: 10.1002/mp.16571

Narrative review-diagnosing and managing malignant epidural spinal cord compression: an evidence-based approach

Akanda ZZ, McKay MJ

(2023), Annals of Translational Medicine, 11, 386

DOI: 10.21037/atm-22-3076

Late, persistent, substantial treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancer

Ong, Wee Loon; Millar, Jeremy Laurence

(2023), Brachytherapy, 22(4), 524-30

DOI: 10.1016/j.brachy.2023.01.001

Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand

O' Callaghan, Michael E.; Roberts, Matthew John; Grummet, Jeremy; Mark, Stephen; Gilbourd, Daniel; Frydenberg, Mark; Millar, Jeremy Laurence; Papa, Nathan Paul

(2023), UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 41(7), 324.e13-324.e20

DOI: 10.1016/j.urolonc.2023.05.011

Real-world data on patterns and outcomes of radiation therapy for brain metastases in a population-based cohort of lung cancer patients in Victoria

Kang, Therese Min Jung; Ratnayake, Gishan Sanaka Bandara; Wada, Morikatsu; Phillips, Claire; Ruben, Jeremy David; Senthi, Sashendra; Foroudi, Farshad; Millar, Jeremy Laurence; Ong, Wee Loon

(2023), Journal of Medical Imaging and Radiation Oncology, 67(5), 546-555

DOI: 10.1111/1754-9485.13545

Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma

Edwards JM, Andrews MC, Burridge H, Smith R, Owens C, Edinger M, Pilkington K, Desfrancois J, Shackleton M, Senthi S, van Zelm MC

(2023), Clinical & Translational Immunology, 12(9), e1466

DOI: 10.1002/cti2.1466

Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)

Muhandiramge J, Warner ET, Zalcberg JR, Haydon A, Polekhina G, van Londen GJ, Gibbs P, Bernstein WB, Tie J, Millar JL, Mar VJ, McNeil JJ, Woods RL, Orchard SG; ASPREE Investigator Group

(2023), Cancers, 15(4), 1017

DOI: 10.3390/cancers15041017

Persisting Gaps in Optimal Care of Stage III Non-small Cell Lung Cancer

Woodford, Katrina Lee; Koo, Kendrick; Reynolds, John; Stirling, Robert; Harden, Susan Victoria; Brand, Margaret Amelia; Senthi, Sashendra

(2023), ONCOLOGIST, 28(2), e92-e102

DOI: 10.1093/oncolo/oyac246

Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose

Ong ALK, Knight K, Panettieri V, Dimmock M, Tuan JKL, Tan HQ, Wright C

(2022), Front Oncol, 12, 1084311

DOI: 10.3389/fonc.2022.1084311

Variations in whole brain radiation therapy fractionation for brain metastases in Victoria

Chee LYS, Sia J, Milne RL, Foroudi F, Millar JL, Ong WL

(2022), J MED IMAG RADIAT ON, 66(8), 1106-14

DOI: 10.1111/1754-9485.13447

Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer

Ong ALK, Knight K, Panettieri V, Dimmock M, Tuan JKL, Tan HQ, Wright C

(2022), Physics and Imaging in Radiation Oncology, 23, 97-102

DOI: 10.1016/j.phro.2022.07.001

Knowledge and insights from a maturing international clinical quality registry

Sampurno F, Kowalski C, Connor SE, Nguyen AV, Acuña ÀP, Ng CF, Foster C, Feick G, Boronat OG, Dieng S, Brglevska S, Ferrante S, Leung S, Villanti P, Moore CM, Graham ID, Millar JL, Litwin MS, Papa N

(2022), J AM MED INFORM ASSN, 29(5), 964-9

DOI: 10.1093/jamia/ocab281

Machine learning predicts cancer subtypes and progression from blood immune signatures

Simon Davis DA, Mun S, Smith JM, Hammill D, Garrett J, Gosling K, Price J, Elsaleh H, Syed FM, Atmosukarto II, Quah BJC

(2022), PLoS One, 17(2), e0264631

DOI: 10.1371/journal.pone.0264631

Codesigning a patient support portal with health professionals and men with prostate cancer: An action research study

Shemesh B, Opie J, Tsiamis E, Ayton D, Satasivam P, Wilton P, Gough K, Lewis K, O'Brien C, Shub M, Pomery A, Mac Manus C, Millar J, Evans S

(2022), Health Expect, 25(4), 1319-31

DOI: 10.1111/hex.13444

Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes

Suzuki G, Yamazaki H, Aibe N, Masui K, Kimoto T, Nagasawa S, Watanabe S, Seri S, Asato A, Shiozaki A, Fujiwara H, Konishi H, Dohi O, Ishikawa T, Elsaleh H, Yamada K

(2022), Radiat Oncol, 17(1), 191

DOI: 10.1186/s13014-022-02162-8

Quantifying the effect email reminders have on patient reported outcome measure returns in a large prostate cancer registry

Papa N, Bensley JG, Hall K, Evans M, Millar JL

(2022), Journal of patient-reported outcomes, 6(1), 19

DOI: 10.1186/s41687-022-00426-1

Comparison of urinary and sexual patient-reported outcomes between open radical prostatectomy and robot-assisted radical prostatectomy: a propensity score matched, population-based study in Victoria

Rechtman M, Forbes A, Millar JL, Evans M, Dodds L, Murphy DG, Evans SM

(2022), BMC Urol, 22(1), 18

DOI: 10.1186/s12894-022-00966-0

Mapping disadvantage: identifying inequities in functional outcomes for prostate cancer survivors based on geography

Koo K, Papa N, Evans M, Jefford M, IJzerman M, White V, Evans SM, Ristevski E, Emery J, Millar J

(2022), BMC Cancer, 22(1), 283

DOI: 10.1186/s12885-022-09389-4

MArkerless image Guidance using Intrafraction Kilovoltage x-ray imaging (MAGIK): study protocol for a phase I interventional study for lung cancer radiotherapy

Mueller M, Booth J, Briggs A, Jayamanne D, Panettieri V, Senthi S, Shieh CC, Keall P

(2022), BMJ Open, 12(1), e057135

DOI: 10.1136/bmjopen-2021-057135

1 2 3